AMARIN INVESTOR ALERT: Gibbs Law Group Has Filed Sole Class Action; Shareholders Should Contact the Firm About Their Rights
March 01 2019 - 5:00PM
Business Wire
Gibbs Law Group filed the only class action lawsuit to date
against Amarin Corporation (NASDAQ: AMRN). The suit is on behalf of
investors who purchased or acquired Amarin securities from
September 24, 2018, through November 8, 2018. The lawsuit seeks to
recover damages for Amarin investors under federal securities
laws.
To speak privately with an attorney regarding this class
action lawsuit, call (800) 808-5294 or click
here.
The class action lawsuit alleges that Amarin and certain of its
officers and directors made false and misleading statements or
failed to disclose that: (1) the top-line results Amarin touted
about its REDUCE-IT trial for Vascepa were not as positive as the
company represented; (2) the placebo given to patients in the
control arm of REDUCE-IT may have increased the incidence of
cardiovascular events in those patients; (3) as a result, Amarin’s
public statements were materially false and misleading at all
relevant times.
If you suffered a loss in Amarin, you have until April 23, 2019,
to request that the Court appoint you as lead plaintiff. You do not
need to be a lead plaintiff in order to share in any recovery.
To speak privately with a securities attorney to learn more
about our investigation and your legal rights, visit our website or
contact our securities team directly at (800) 808-5294.
About Gibbs Law Group
Gibbs Law Group represents individual and institutional
investors in securities litigation, financial fraud and other
complex litigation. We have recovered over a billion dollars for
its clients against some of the world’s largest corporations, and
our attorneys have received numerous honors for their work,
including “Best Lawyers in America,” “Top Plaintiff Lawyers in
California,” “Top Class Action Attorneys Under 40,” “Consumer
Protection MVP,” and “Top Cybersecurity/ Privacy Attorneys Under
40.”
This press release may constitute Attorney Advertising in some
jurisdictions under the applicable law and ethical rules.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20190301005561/en/
EILEEN EPSTEIN510.350.9728EJE@CLASSLAWGROUP.COM
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Amarin (NASDAQ:AMRN)
Historical Stock Chart
From Sep 2023 to Sep 2024